OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Synthesis of New Organoselenium-Based Succinanilic and Maleanilic Derivatives and In Silico Studies as Possible SARS-CoV-2 Main Protease Inhibitors
Saad Shaaban, Yasair S. Al-Faiyz, Ghayah M. Alsulaim, et al.
Inorganics (2023) Vol. 11, Iss. 8, pp. 321-321
Open Access | Times Cited: 50

Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 41

Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 39

Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies
Samia M. Al-Muntaser, Ahmed A. Al‐Karmalawy, Abeer M. El‐Naggar, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12184-12203
Open Access | Times Cited: 25

Some pyrimidohexahydroquinoline candidates: synthesis, DFT, cytotoxic activity evaluation, molecular docking, and in silico studies
Sayed K. Ramadan, Hisham S. M. Abd‐Rabboh, Amal A. Abdel Hafez, et al.
RSC Advances (2024) Vol. 14, Iss. 23, pp. 16584-16599
Open Access | Times Cited: 8

Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment
Ahmed A. Al‐Karmalawy, Mohamed A. Zeidan, Ayman Abo Elmaaty, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108159-108159
Closed Access

Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 26

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro , molecular docking, molecular dynamics, and SAR studies
Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18

Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses
Andrea Citarella, Davide Moi, Martina Pedrini, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 18, pp. 3811-3824
Open Access | Times Cited: 18

Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments
Ahmed A. Al‐Karmalawy, Mai H. A. Mousa, Marwa Sharaky, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 492-512
Closed Access | Times Cited: 13

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N -(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
Ahmed A. Al‐Karmalawy, Dalia S. El‐Gamil, Rabeh El‐Shesheny, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 12

Metabolites profiling, in-vitro and molecular docking studies of five legume seeds for Alzheimer’s disease
Rana M. Ibrahim, Passent M. Abdel-Baki, Osama G. Mohamed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction
Ahmed A. Abdel Gaber, Ayman Abo Elmaaty, Marwa Sharaky, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107223-107223
Closed Access | Times Cited: 2

Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment
Marwa Abdel‐Motaal, Dalal Ali Aldakhili, Ayman Abo Elmaaty, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 2

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
Enrico M. A. Fassi, Marco Manenti, Andrea Citarella, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2356-2356
Open Access | Times Cited: 6

Design and Synthesis of Novel Pyrazolopyrimidine Candidates As Promising EGFR-T790M Inhibitors and Apoptosis Inducers
Ahmed A. Abdel Gaber, Marwa Sharaky, Ayman Abo Elmaaty, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1773-1790
Open Access | Times Cited: 6

Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects
Ashraf K. El‐Damasy, Jong‐Min Oh, Hyun Ji Kim, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106939-106939
Closed Access | Times Cited: 6

Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile ; in silico and in Vitro assessments with structure-activity relationship
Ahmed A. Al‐Karmalawy, Radwan Alnajjar, Ayman Abo Elmaaty, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6941-6953
Open Access | Times Cited: 5

Rational Design Problematics of Peptide Nucleic Acids as SARS-CoV-2 Inhibitors
Tatyana A. Grigoreva, Светлана В. Ворона, Daria Novikova, et al.
ACS Omega (2024)
Open Access | Times Cited: 1

Spectral Analysis of Novel Minocycline/Zn Complex with Promising Anticancer Activities Against Large Lung Cancer Cells (H460), Antibacterial and Antioxidant Activities Against Acrylamide-Induced Pulmonary Toxicity in Male Rats
Samy M. El-Megharb, Bander Albogami, Shahira A. Hassoubah, et al.
International Journal of Pharmacology (2024) Vol. 20, Iss. 7, pp. 1247-1270
Closed Access | Times Cited: 1

Synthesis and spectroscopic study of novel mixed ligand formula “Artemisinin/Zn” and assessment of its inhibitory effect against “SARS-CoV-2″
Fawziah A. Al‐Salmi, Samy M. El‐Megharbel, Reham Z. Hamza
Heliyon (2023) Vol. 9, Iss. 6, pp. e17177-e17177
Open Access | Times Cited: 2

LC‐HRMS Profiling and Cytotoxic Potential of Actinomycetes Associated with the Red Sea Soft Coral Sarcophyton glaucum: In vitro and In silico Studies
Seham S. El‐Hawary, Marwa H. A. Hassan, Ahmed O. Hudhud, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 3
Closed Access

Page 1 - Next Page

Scroll to top